
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effect of vaccination on household transmission of SARS-CoV-2 Delta variant of concern
Frederik Plesner Lyngse, Kåre Mølbak, Matt Denwood, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 39
Frederik Plesner Lyngse, Kåre Mølbak, Matt Denwood, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 39
Showing 1-25 of 39 citing articles:
Long-term effectiveness of COVID-19 vaccines against infections, hospitalisations, and mortality in adults: findings from a rapid living systematic evidence synthesis and meta-analysis up to December, 2022
Nana Wu, Keven Joyal‐Desmarais, Paula Aver Bretanha Ribeiro, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 5, pp. 439-452
Open Access | Times Cited: 187
Nana Wu, Keven Joyal‐Desmarais, Paula Aver Bretanha Ribeiro, et al.
The Lancet Respiratory Medicine (2023) Vol. 11, Iss. 5, pp. 439-452
Open Access | Times Cited: 187
The role of children in household transmission of COVID-19: a systematic review and meta-analysis
Feifan Chen, Yan Tian, Lixin Zhang, et al.
International Journal of Infectious Diseases (2022) Vol. 122, pp. 266-275
Open Access | Times Cited: 67
Feifan Chen, Yan Tian, Lixin Zhang, et al.
International Journal of Infectious Diseases (2022) Vol. 122, pp. 266-275
Open Access | Times Cited: 67
Seroprevalence and infection fatality rate of the SARS-CoV-2 Omicron variant in Denmark: A nationwide serosurveillance study
Christian Erikstrup, Anna Laksafoss, Josephine Gladov, et al.
The Lancet Regional Health - Europe (2022) Vol. 21, pp. 100479-100479
Open Access | Times Cited: 50
Christian Erikstrup, Anna Laksafoss, Josephine Gladov, et al.
The Lancet Regional Health - Europe (2022) Vol. 21, pp. 100479-100479
Open Access | Times Cited: 50
A comparative overview of SARS‑CoV‑2 and its variants of concern
Aqeel Ahmad, Mirna Fawaz, Arafeen Aisha
Infezioni in Medicina (2022) Vol. 30, Iss. 3
Open Access | Times Cited: 37
Aqeel Ahmad, Mirna Fawaz, Arafeen Aisha
Infezioni in Medicina (2022) Vol. 30, Iss. 3
Open Access | Times Cited: 37
Risk, sanctions and norm change: the formation and decay of social distancing norms
Eva Vriens, Giulia Andrighetto, Luca Tummolini
Philosophical Transactions of the Royal Society B Biological Sciences (2024) Vol. 379, Iss. 1897
Open Access | Times Cited: 12
Eva Vriens, Giulia Andrighetto, Luca Tummolini
Philosophical Transactions of the Royal Society B Biological Sciences (2024) Vol. 379, Iss. 1897
Open Access | Times Cited: 12
Effectiveness and durability of BNT162b2 vaccine against hospital and emergency department admissions due to SARS-CoV-2 omicron sub-lineages BA.1 and BA.2 in a large health system in the USA: a test-negative, case-control study
Sara Y. Tartof, Jeff Slezak, Laura Puzniak, et al.
The Lancet Respiratory Medicine (2022) Vol. 11, Iss. 2, pp. 176-187
Open Access | Times Cited: 28
Sara Y. Tartof, Jeff Slezak, Laura Puzniak, et al.
The Lancet Respiratory Medicine (2022) Vol. 11, Iss. 2, pp. 176-187
Open Access | Times Cited: 28
A self-amplifying RNA vaccine prevents enterovirus D68 infection and disease in preclinical models
Nikole L. Warner, Jacob Archer, Stephanie Park, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 759
Closed Access | Times Cited: 6
Nikole L. Warner, Jacob Archer, Stephanie Park, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 759
Closed Access | Times Cited: 6
Impact of disease severity, age, sex, comorbidity, and vaccination on secondary attack rates of SARS-CoV-2: a global systematic review and meta-analysis
Dewan Md. Sumsuzzman, Yang Ye, Zhen Wang, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Dewan Md. Sumsuzzman, Yang Ye, Zhen Wang, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Effect of COVID-19 vaccination on household transmission of SARS-CoV-2 in the Omicron era: The Vaccine Effectiveness, Networking, and Universal Safety (VENUS) study
Megumi Maeda, Fumiko Murata, Haruhisa Fukuda
International Journal of Infectious Diseases (2023) Vol. 134, pp. 200-206
Open Access | Times Cited: 11
Megumi Maeda, Fumiko Murata, Haruhisa Fukuda
International Journal of Infectious Diseases (2023) Vol. 134, pp. 200-206
Open Access | Times Cited: 11
Policies on children and schools during the SARS-CoV-2 pandemic in Western Europe
Antoni Soriano‐Arandes, Ana Brett, Danilo Buonsenso, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 11
Antoni Soriano‐Arandes, Ana Brett, Danilo Buonsenso, et al.
Frontiers in Public Health (2023) Vol. 11
Open Access | Times Cited: 11
The extent and impact of vaccine status miscategorisation on covid-19 vaccine efficacy studies
Martin Neil, Scott McLachlan, Norman Fenton
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
Martin Neil, Scott McLachlan, Norman Fenton
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 3
The impact of quality-adjusted life years on evaluating COVID-19 mitigation strategies: lessons from age-specific vaccination roll-out and variants of concern in Belgium (2020-2022)
Lander Willem, Steven Abrams, Nicolas Franco, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Lander Willem, Steven Abrams, Nicolas Franco, et al.
BMC Public Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 3
How effective is the BNT162b2 mRNA vaccine against SARS-CoV-2 transmission and infection? A national programme analysis in Monaco, July 2021 to September 2022
Thomas Althaus, Christopher E. Overton, Isabelle Devaux, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Thomas Althaus, Christopher E. Overton, Isabelle Devaux, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 3
Susceptibility and infectiousness of SARS-CoV-2 in children versus adults, by variant (wild-type, alpha, delta): A systematic review and meta-analysis of household contact studies
Olalekan A Uthman, Frederik Plesner Lyngse, Seun Anjorin, et al.
PLoS ONE (2024) Vol. 19, Iss. 9, pp. e0306740-e0306740
Open Access | Times Cited: 3
Olalekan A Uthman, Frederik Plesner Lyngse, Seun Anjorin, et al.
PLoS ONE (2024) Vol. 19, Iss. 9, pp. e0306740-e0306740
Open Access | Times Cited: 3
The role of children in transmission of SARS-CoV-2 variants of concern within households: an updated systematic review and meta-analysis, as at 30 June 2022
Yanshan Zhu, Yao Xia, Janessa Pickering, et al.
Eurosurveillance (2023) Vol. 28, Iss. 18
Open Access | Times Cited: 9
Yanshan Zhu, Yao Xia, Janessa Pickering, et al.
Eurosurveillance (2023) Vol. 28, Iss. 18
Open Access | Times Cited: 9
Estimation of introduction and transmission rates of SARS-CoV-2 in a prospective household study
Michiel van Boven, Christiaan H. van Dorp, Ilse Westerhof, et al.
PLoS Computational Biology (2024) Vol. 20, Iss. 1, pp. e1011832-e1011832
Open Access | Times Cited: 2
Michiel van Boven, Christiaan H. van Dorp, Ilse Westerhof, et al.
PLoS Computational Biology (2024) Vol. 20, Iss. 1, pp. e1011832-e1011832
Open Access | Times Cited: 2
COVID-19 vaccine effectiveness against SARS-CoV-2 infection during the Delta period, a nationwide study adjusting for chance of exposure, the Netherlands, July to December 2021
Catharina E van Ewijk, Marjolein N. Kooijman, Ewout Fanoy, et al.
Eurosurveillance (2022) Vol. 27, Iss. 45
Open Access | Times Cited: 11
Catharina E van Ewijk, Marjolein N. Kooijman, Ewout Fanoy, et al.
Eurosurveillance (2022) Vol. 27, Iss. 45
Open Access | Times Cited: 11
Impact of Vaccination With the SCB-2019 Coronavirus Disease 2019 Vaccine on Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Household Contact Study in the Philippines
Birkneh Tilahun Tadesse, Lulu Bravo, Florian Marks, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 7, pp. 1180-1187
Open Access | Times Cited: 9
Birkneh Tilahun Tadesse, Lulu Bravo, Florian Marks, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 7, pp. 1180-1187
Open Access | Times Cited: 9
Ally, adversary, or arbitrator? The context-dependent role of eosinophils in vaccination for respiratory viruses and subsequent breakthrough infections
Lauren A. Chang, Michael Schotsaert
Journal of Leukocyte Biology (2024)
Open Access | Times Cited: 1
Lauren A. Chang, Michael Schotsaert
Journal of Leukocyte Biology (2024)
Open Access | Times Cited: 1
Monitoring epidemic processes under political measures
Nataliya Chukhrova, Oskar Plate, Arne Johannssen
Statistics in Medicine (2024) Vol. 43, Iss. 11, pp. 2122-2160
Open Access | Times Cited: 1
Nataliya Chukhrova, Oskar Plate, Arne Johannssen
Statistics in Medicine (2024) Vol. 43, Iss. 11, pp. 2122-2160
Open Access | Times Cited: 1
Lower levels of household transmission of SARS-CoV-2 VOC Omicron compared to Wild-type: an interplay between transmissibility and immune status
Angelique M A M Winkel, Eva Kozanli, Milly Haverkort, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 1
Angelique M A M Winkel, Eva Kozanli, Milly Haverkort, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access | Times Cited: 1
High-resolution epidemiological landscape from ~290,000 SARS-CoV-2 genomes from Denmark
Mark P. Khurana, Jacob Curran-Sebastian, Neil Scheidwasser-Clow, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Mark P. Khurana, Jacob Curran-Sebastian, Neil Scheidwasser-Clow, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Does the COVID-19 Vaccination Reduce the Risk to Transmit SARS-CoV-2 to Others?
Günter Kampf
Advances in experimental medicine and biology (2024), pp. 247-264
Closed Access | Times Cited: 1
Günter Kampf
Advances in experimental medicine and biology (2024), pp. 247-264
Closed Access | Times Cited: 1
Do we need nasal vaccines against COVID 19 to suppress the transmission of infections?
Harald Brüssow
Microbial Biotechnology (2022) Vol. 16, Iss. 1, pp. 3-14
Open Access | Times Cited: 8
Harald Brüssow
Microbial Biotechnology (2022) Vol. 16, Iss. 1, pp. 3-14
Open Access | Times Cited: 8
mRNA vaccine effectiveness against SARS-CoV-2 B.1.617.2 (Delta) and B.1.1.529 (Omicron) variant transmission from home care cases to household contacts in South Korea
Hanul Park, Young-Joon Park, Sang Eun Lee, et al.
Osong Public Health and Research Perspectives (2022) Vol. 13, Iss. 6, pp. 435-442
Open Access | Times Cited: 5
Hanul Park, Young-Joon Park, Sang Eun Lee, et al.
Osong Public Health and Research Perspectives (2022) Vol. 13, Iss. 6, pp. 435-442
Open Access | Times Cited: 5